Name: Peter Ludwig at NYBA 22nd Annual Meeting
Start: 2013-05-29T05:00

Why Fish

Diversity, Equity & Inclusion

Pro Bono

Partner Organizations

Legal Operations

Pricing

Legal Project Management

Knowledge Management

eDiscovery

Legal Technology Services

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Appellate

Chancery & Corporate Governance

Post-Grant

Inter Partes Review

Post-Grant Review

Ex Parte Reexamination

Supplemental Examination

Patent

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Industries

Electrical & Computer Technology

Artificial Intelligence

Digital Health

Digital Media & E-Commerce

Financial, Business & FinTech Services

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Post-Grant Annual Reports

Hosts

Name

S. Peter Ludwig

Person title

Senior Principal

Fish’s Peter Ludwig presented at the 22nd annual meeting of the NY Biotechnology Association.

NYBA 22nd Annual Meeting

Hosts

Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

Legal Alert: EPO Enlarged Board of Appeal Raises Bar for Challenging Priority Claims at the EPO

New Admission Criteria to Practice Before USPTO Designed to Foster Diversity and Promote Innovation

Legal Alert: Minimizing Patent TRO and PI Risk in Europe

Principals Anita Meiklejohn and Caleb Bates Co-Author Article for One Nucleus Annual Review 2023

Legal Alert: The USPTO’s Transition to Electronic Patent Issuance and Reduction in Period Between Issue Notification and Issue Date

Senior Principal Terry Mahn Authors Medical Device + Diagnostic Industry Article "This Company's False Compliance With CISPR 11 Resulted in a $12 Million FCA...

Principals Patrick Darno and Peter Fasse Author "Patent Strategies for Protecting Bioinformatics Inventions" for IAM

Fish & Richardson Attorneys Author IAM Article "Neglect Begets Opportunity in Femtech IP"

Principal Michael Shepherd Authors Law360 Expert Analysis, "Why PTAB 'Step 2B' Reversal Rates Are Falling"